SCOPUS 정보 검색 플랫폼

Diabetes Care

Volumn 39, Issue 10, 2016, Pages e165-e166

A case of euglycemic diabetic ketoacidosis following long-term empagliflozin therapy

(3) Farjo, Peter D a Kidd, Kacie M a Reece, Josephine L a

a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ANTIEMETIC AGENT; BICARBONATE; EDIBLE OIL; EMPAGLIFLOZIN; GLUCOSE; HEMOGLOBIN A1C; INFUSION FLUID; INSULIN; KRILL OIL; UNCLASSIFIED DRUG;

ADULT; ANION GAP; BLOOD GAS ANALYSIS; BLOOD PH; BREATHING RATE; CARBON DIOXIDE TENSION; CASE REPORT; CHRONIC DRUG ADMINISTRATION; DIABETIC KETOACIDOSIS; DISEASE DURATION; DIZZINESS; DRUG CAPSULE; DRUG RESPONSE; DRUG USE; EMERGENCY WARD; EUGLYCEMIC DIABETIC KETOACIDOSIS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERVENTILATION; LABORATORY TEST; LETTER; LONG TERM CARE; LOW CARBOHYDRATE DIET; MALE; MIDDLE AGED; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESYNCOPE; RESPIRATORY ALKALOSIS; SCLEROTHERAPY; TACHYPNEA; TREATMENT DURATION;

EID: 84988964991 PISSN: 01495992 EISSN: 19355548 Source Type: Journal
DOI: 10.2337/dc16-0728 Document Type: Letter

Times cited : (12)

References (5)

1
- 84962439093
- Euglycemic diabetic ketoacidosis: A predictable, detectable, and preventable safety concern with SGLT2 inhibitors
- Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: A predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care 2015;38: 1638-1642
- (2015) Diabetes Care , vol.38 , pp. 1638-1642
- Rosenstock, J.¹ Ferrannini, E.²

2
- 84954027777
- U.S. Food and Drug Administration, [article online] Accessed 19 March 2016
- U.S. Food and Drug Administration. FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of toomuch acid in the blood [article online], 2015. Available fromhttp:// www.fda.gov/downloads/Drugs/DrugSafety/ UCM446954.pdf. Accessed 19 March 2016
- (2015) FDA Warns That SGLT2 Inhibitors for Diabetes May Result in A Serious Condition of Toomuch Acid in the Blood

3
- 84962339296
- Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition
- Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 2015;38:1687-1693
- (2015) Diabetes Care , vol.38 , pp. 1687-1693
- Peters, A.L.¹ Buschur, E.O.² Buse, J.B.³ Cohan, P.⁴ Diner, J.C.⁵ Hirsch, I.B.⁶

4
- 84962050697
- Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes after treatment with empagliflozin
- Roach P, Skierczynski P. Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes after treatment with empagliflozin. Diabetes Care 2016;39:e3
- (2016) Diabetes Care , vol.39 , pp. e3
- Roach, P.¹ Skierczynski, P.²

5
- 84913617433
- A brief review of krill oil history, research, and the commercial market
- Kwantes JM, Grundmann O. A brief review of krill oil history, research, and the commercial market. J Diet Suppl 2013;0211: 1-13
- (2013) J Diet Suppl , vol.211 , pp. 1-13
- Kwantes, J.M.¹ Grundmann, O.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.